Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Unvaccinated adults cost the US more than $7 billion a year
Vaccine-preventable diseases among adults cost the U.
Major depressive disorder market will reach $5.8 billion by 2025 as awareness and drugs improve, says GlobalData
The major depressive disorder (MDD) market, which covers various forms of depression and seasonal affective disorder, is set to rise from $3.
PanOptica Reports Positive Results from Phase 1/2 Clinical Trial of PAN-90806, a Novel Topical Anti-VEGF Eye Drop
BERNARDSVILLE, NJ, USA I October 14, 2016 I PanOptica, Inc.
Trevi Therapeutics Announces Positive Results from Phase 2 Trial in Prurigo Nodularis
NEW HAVEN, CT, USA I October 13, 2016 I Trevi Therapeutics, Inc.
Generic drugs “save European 100 billion euros per year”
Through generic medicine competition, twice as many patients were able to get treatment without any impact on the treatment cost, according to the conclusions of the IMS Institute for Healthcare Infor...
Major depressive disorder market will reach $5.8 billion by 2025 as awareness and drugs improve, says GlobalData
The major depressive disorder (MDD) market, which covers various forms of depression and seasonal affective disorder, is set to rise from $3.
FDA cites two European companies in separate warning letters
The FDA named two European drug manufacturers--Delarange Cosmetics & Healthcare of the Netherlands and Wallace Cameron of the U.
AZD9412 Clinical Trial Update
SOUTHAMPTON, UK I October 12, 2016 I Synairgen plc (LSE.
WHO reaches out to API makers to get prequalification for much-needed drugs
As part of its efforts to expand access and make certain drugs more affordable for the treatment of a variety diseases and conditions, the World Health Organization is inviting API manufacturers to ap...
Curis Expands Oncology Pipeline with an Oral Small Molecule PD-L1/TIM-3 Immune Checkpoint Antagonist
LEXINGTON, MA, USA I October 11, 2016 I Curis, Inc.
US clears Lundbeck’s IV epilepsy drug Carnexiv
US regulators have approved Lundbeck's Carnexiv, the first intravenous formulation of epilepsy drug carbamazepine.
Exelixis and Pfizer drugs compete in kidney cancer trial
Exelixis's drug Cabometyx outperformed Pfizer's Sutent in a clinical study for the treatment of metastatic kidney cancer, suggesting it has the potential to become a first-line treatment, rese...
597
598
599
600
601
602
603
604
605
